PGXL Laboratories and Silicon Biosystems S.p.A. Collaborate to Offer Clinical Research Services Focused on Oncology Genomics
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LOUISVILLE, Ky.--(BUSINESS WIRE)--PGXL Technologies and Silicon Biosystems, Inc. announced a collaborative partnership to make the highly regarded Silicon Biosystems DEPArray technology available through PGXL Technologies. The PGXL program will allow clinical researchers and pharma sponsors to obtain the level of data fidelity and resolution needed in cancer biomarker discovery and translational research.
Help employers find you! Check out all the jobs and post your resume.
LOUISVILLE, Ky.--(BUSINESS WIRE)--PGXL Technologies and Silicon Biosystems, Inc. announced a collaborative partnership to make the highly regarded Silicon Biosystems DEPArray technology available through PGXL Technologies. The PGXL program will allow clinical researchers and pharma sponsors to obtain the level of data fidelity and resolution needed in cancer biomarker discovery and translational research.
“As the DEPArray technology has gained recognition in the marketplace for its unmatched ability to recover pure cells for molecular characterization, we have received significant interest in having the platform available on a fee-for-service basis,” said Bob Proulx, President and General Manager of Silicon Biosystems’ U.S. operations. “Last year we added a demonstration and training lab, but partnering with PGXL for CRO services will add a whole new dimension to our ability to reach and impact the market.”
Help employers find you! Check out all the jobs and post your resume.